Home/Filings/4/0001104659-20-072062
4//SEC Filing

FEINBERG LARRY N 4

Accession 0001104659-20-072062

CIK 0000811240other

Filed

Jun 9, 8:00 PM ET

Accepted

Jun 10, 5:05 PM ET

Size

20.9 KB

Accession

0001104659-20-072062

Insider Transaction Report

Form 4
Period: 2020-06-08
Transactions
  • Sale

    Common Stock

    2020-06-08$0.55/sh358,744$198,816264,141 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-06-08$0.55/sh564,738$312,978713,896 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-06-09$0.55/sh435,596$240,188278,300 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-06-09$0.55/sh47,885$26,2700 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-06-09$0.55/sh10,400$5,7280 total(indirect: See footnote)
  • Sale

    Common Stock, par value $0.001 per share ("Common Stock")

    2020-06-08$0.55/sh2,479,456$1,374,1152,473,090 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-06-09$0.55/sh1,196,590$659,8001,276,500 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-06-09$0.55/sh79,841$44,024184,300 total(indirect: See footnote)
Transactions
  • Sale

    Common Stock

    2020-06-09$0.55/sh435,596$240,188278,300 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-06-09$0.55/sh79,841$44,024184,300 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-06-09$0.55/sh10,400$5,7280 total(indirect: See footnote)
  • Sale

    Common Stock, par value $0.001 per share ("Common Stock")

    2020-06-08$0.55/sh2,479,456$1,374,1152,473,090 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-06-09$0.55/sh1,196,590$659,8001,276,500 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-06-08$0.55/sh564,738$312,978713,896 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-06-08$0.55/sh358,744$198,816264,141 total(indirect: See footnote)
  • Sale

    Common Stock

    2020-06-09$0.55/sh47,885$26,2700 total(indirect: See footnote)
Footnotes (7)
  • [F1]These securities are owned by Oracle Partners, LP. ("Partners").
  • [F2]These securities are owned by Oracle Ten Fund, L.P. ("Ten Fund").
  • [F3]These securities are owned by Oracle Institutional Partners, L.P. ("Institutional Partners")
  • [F4]These securities are owned by Oracle Investment Management, Inc. Employees Retirement Plan ("Retirement Plan").
  • [F5]These securities are owned by Feinberg Family Foundation ("Foundation").
  • [F6]Larry N. Feinberg serves as the managing member of Oracle Associates, LLC, the general partner of Partners, Institutional Partners and Ten Fund, and accordingly, may be deemed to be the indirect beneficial owner of the shares beneficially owned by Partners, Institutional Partners and Ten Fund. Mr. Feinberg is the sole shareholder, director and president of Oracle Investment Management, Inc., which serves as investment manager to Partners, Institutional Partners, Ten Fund and Retirement Plan, and accordingly, may be deemed to be the beneficial owner of the shares beneficially owned by Partners, Institutional Partners, Ten Fund and Retirement Plan. Mr. Feinberg serves as the Trustee of the Foundation, and accordingly, may be deemed to be the beneficial owner of the shares beneficially owned by the Foundation.
  • [F7]Each of the Reporting Persons identified in this statement disclaims beneficial ownership of the securities described in this statement, except to the extent of their individual respective pecuniary interest in such securities. The filing of this statement shall not be deemed an admission that any of the Reporting Persons identified in this statement are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any securities specified in this statement other than those directly beneficially owned by them.

Issuer

BIOLASE, INC

CIK 0000811240

Entity typeother
IncorporatedNY

Related Parties

1
  • filerCIK 0000926475

Filing Metadata

Form type
4
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 5:05 PM ET
Size
20.9 KB